Published in Mol Cell Biol on July 01, 1991
The alpha-mating type locus of Cryptococcus neoformans contains a peptide pheromone gene. Mol Cell Biol (1993) 2.81
Shk1, a homolog of the Saccharomyces cerevisiae Ste20 and mammalian p65PAK protein kinases, is a component of a Ras/Cdc42 signaling module in the fission yeast Schizosaccharomyces pombe. Proc Natl Acad Sci U S A (1995) 2.33
Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother (1994) 2.23
Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc Natl Acad Sci U S A (1992) 2.10
Pheromones trigger filamentous growth in Ustilago maydis. EMBO J (1994) 2.07
FAR1 is required for oriented polarization of yeast cells in response to mating pheromones. J Cell Biol (1995) 1.87
Dual roles for Ste24p in yeast a-factor maturation: NH2-terminal proteolysis and COOH-terminal CAAX processing. J Cell Biol (1998) 1.75
Saccharomyces cerevisiae cells execute a default pathway to select a mate in the absence of pheromone gradients. J Cell Biol (1995) 1.72
The a-factor transporter (STE6 gene product) and cell polarity in the yeast Saccharomyces cerevisiae. J Cell Biol (1993) 1.67
A large pheromone and receptor gene complex determines multiple B mating type specificities in Coprinus cinereus. Genetics (1998) 1.58
Biogenesis of the Saccharomyces cerevisiae mating pheromone a-factor. J Cell Biol (1997) 1.57
Genetic evidence for in vivo cross-specificity of the CaaX-box protein prenyltransferases farnesyltransferase and geranylgeranyltransferase-I in Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.50
Fungal lipopeptide mating pheromones: a model system for the study of protein prenylation. Microbiol Rev (1995) 1.48
Sexual pheromones and mating responses in fungi. Plant Cell (1993) 1.48
Asymmetry in sexual pheromones is not required for ascomycete mating. Curr Biol (2011) 1.46
Nucleotide sequence of the yeast STE14 gene, which encodes farnesylcysteine carboxyl methyltransferase, and demonstration of its essential role in a-factor export. Mol Cell Biol (1994) 1.43
Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein. Mol Cell Biol (1992) 1.39
The Saccharomyces cerevisiae prenylcysteine carboxyl methyltransferase Ste14p is in the endoplasmic reticulum membrane. Mol Biol Cell (1998) 1.36
Multiple sex pheromones and receptors of a mushroom-producing fungus elicit mating in yeast. Mol Biol Cell (1999) 1.19
Mutations that alter the third cytoplasmic loop of the a-factor receptor lead to a constitutive and hypersensitive phenotype. Proc Natl Acad Sci U S A (1993) 1.14
Biogenesis of the Saccharomyces cerevisiae pheromone a-factor, from yeast mating to human disease. Microbiol Mol Biol Rev (2012) 1.13
Role of the ABC transporter Ste6 in cell fusion during yeast conjugation. J Cell Biol (1996) 1.09
Small-molecule inhibitors of the Rce1p CaaX protease. J Biomol Screen (2007) 1.03
Endoproteolytic processing of a farnesylated peptide in vitro. Proc Natl Acad Sci U S A (1992) 1.03
Mutations within the first LSGGQ motif of Ste6p cause defects in a-factor transport and mating in Saccharomyces cerevisiae. J Bacteriol (1996) 1.01
Mutational analysis of the ras converting enzyme reveals a requirement for glutamate and histidine residues. J Biol Chem (2005) 1.01
Saccharomyces cerevisiae a-factor mutants reveal residues critical for processing, activity, and export. Eukaryot Cell (2006) 1.01
Consequences of altered isoprenylation targets on a-factor export and bioactivity. Proc Natl Acad Sci U S A (1994) 0.92
A role for a complex between activated G protein-coupled receptors in yeast cellular mating. Proc Natl Acad Sci U S A (2007) 0.91
Prenylcysteine alpha-carboxyl methyltransferase in suspension-cultured tobacco cells Plant Physiol (1998) 0.91
Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones. Biochim Biophys Acta (2007) 0.91
Genes encoding farnesyl cysteine carboxyl methyltransferase in Schizosaccharomyces pombe and Xenopus laevis. Mol Cell Biol (1997) 0.90
Localization and signaling of G(beta) subunit Ste4p are controlled by a-factor receptor and the a-specific protein Asg7p. Mol Cell Biol (2000) 0.89
The posttranslational processing of ras p21 is critical for its stimulation of yeast adenylate cyclase. Mol Cell Biol (1992) 0.85
Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology. Bioorg Med Chem (2010) 0.84
Synthesis of peptides containing C-terminal methyl esters using trityl side-chain anchoring: application to the synthesis of a-factor and a-factor analogs. Org Lett (2012) 0.80
A common genetic system for functional studies of pitrilysin and related M16A proteases. Biochem J (2006) 0.77
Synthesis of Peptides Containing C-Terminal Esters Using Trityl Side-Chain Anchoring: Applications to the Synthesis of C-Terminal Ester Analogs of the Saccharomyces cerevisiae Mating Pheromone a-Factor. J Org Chem (2015) 0.75
A shunt pathway limits the CaaX processing of Hsp40 Ydj1p and regulates Ydj1p-dependent phenotypes. Elife (2016) 0.75
Regulation of the mevalonate pathway. Nature (1990) 18.25
Reversible arrest of haploid yeast cells in the initiation of DNA synthesis by a diffusible sex factor. Exp Cell Res (1973) 10.93
All ras proteins are polyisoprenylated but only some are palmitoylated. Cell (1989) 9.68
Two genes required for cell fusion during yeast conjugation: evidence for a pheromone-induced surface protein. Mol Cell Biol (1987) 7.38
Mutants of Saccharomyces cerevisiae unresponsive to cell division control by polypeptide mating hormone. J Cell Biol (1980) 6.94
A regulatory hierarchy for cell specialization in yeast. Nature (1989) 5.68
p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci U S A (1989) 4.80
The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature (1989) 4.63
Synchronization of haploid yeast cell cycles, a prelude to conjugation. Exp Cell Res (1973) 4.58
Life cycle of the budding yeast Saccharomyces cerevisiae. Microbiol Rev (1988) 4.55
Isolation and genetic analysis of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and alpha factor pheromones. Mol Cell Biol (1982) 4.54
Identification of a gene necessary for cell cycle arrest by a negative growth factor of yeast: FAR1 is an inhibitor of a G1 cyclin, CLN2. Cell (1990) 4.27
Identification and regulation of a gene required for cell fusion during mating of the yeast Saccharomyces cerevisiae. Mol Cell Biol (1987) 4.17
Saccharomyces cerevisiae STE6 gene product: a novel pathway for protein export in eukaryotic cells. EMBO J (1989) 4.10
Posttranslational modification of the Ha-ras oncogene protein: evidence for a third class of protein carboxyl methyltransferases. Proc Natl Acad Sci U S A (1988) 4.04
Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science (1989) 3.90
The a-factor pheromone of Saccharomyces cerevisiae is essential for mating. Mol Cell Biol (1988) 3.62
RAM, a gene of yeast required for a functional modification of RAS proteins and for production of mating pheromone a-factor. Cell (1986) 3.57
Conjugation in Saccharomyces cerevisiae. Annu Rev Cell Biol (1988) 3.47
Structure of Saccharomyces cerevisiae mating hormone a-factor. Identification of S-farnesyl cysteine as a structural component. J Biol Chem (1988) 3.42
Physiological characterization of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and alpha factor pheromones. Mol Cell Biol (1982) 3.37
A yeast operator overlaps an upstream activation site. Cell (1987) 3.33
Recovery of S. cerevisiae a cells from G1 arrest by alpha factor pheromone requires endopeptidase action. Cell (1979) 3.23
Prenyl proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem Sci (1990) 3.12
Morphogenic effects of alpha-factor on Saccharomyces cerevisiae a cells. J Bacteriol (1976) 3.02
Courtship in S. cerevisiae: both cell types choose mating partners by responding to the strongest pheromone signal. Cell (1990) 2.87
Cell-cell recognition in Saccharomyces cerevisiae: regulation of mating-specific adhesion. J Bacteriol (1978) 2.76
Induction of the yeast alpha-specific STE3 gene by the peptide pheromone a-factor. J Mol Biol (1984) 2.41
Enzymatic coupling of cholesterol intermediates to a mating pheromone precursor and to the ras protein. Science (1990) 2.04
Alpha-factor structural gene mutations in Saccharomyces cerevisiae: effects on alpha-factor production and mating. Mol Cell Biol (1985) 1.97
Modification of nuclear lamin proteins by a mevalonic acid derivative occurs in reticulocyte lysates and requires the cysteine residue of the C-terminal CXXM motif. EMBO J (1989) 1.96
Sexual conjugation in yeast. Cell surface changes in response to the action of mating hormones. J Cell Biol (1979) 1.94
The yeast repeated element sigma contains a hormone-inducible promoter. Mol Cell Biol (1987) 1.88
Identification of geranylgeranyl-modified proteins in HeLa cells. Science (1990) 1.88
Courtship in Saccharomyces cerevisiae: an early cell-cell interaction during mating. Mol Cell Biol (1990) 1.82
Prenylated proteins: the structure of the isoprenoid group. Science (1990) 1.82
Structure of rhodotorucine A, a novel lipopeptide, inducing mating tube formation in Rhodosporidium toruloides. Biochem Biophys Res Commun (1978) 1.74
Farnesyl cysteine C-terminal methyltransferase activity is dependent upon the STE14 gene product in Saccharomyces cerevisiae. Mol Cell Biol (1990) 1.67
Membrane lipid phase as catalyst for peptide-receptor interactions. Proc Natl Acad Sci U S A (1986) 1.61
Common modifications of trimeric G proteins and ras protein: involvement of polyisoprenylation. Science (1990) 1.43
RAS2 protein of Saccharomyces cerevisiae is methyl-esterified at its carboxyl terminus. J Biol Chem (1989) 1.39
Control of yeast mating signal transduction by a mammalian beta 2-adrenergic receptor and Gs alpha subunit. Science (1990) 1.28
Role of metabolism of the mating pheromone in sexual differentiation of the heterobasidiomycete Rhodosporidium toruloides. J Bacteriol (1982) 1.21
Requirements of chemical structure of hormonal activity of lipopeptidyl factors inducing sexual differentiation in vegetative cells of heterobasidiomycetous yeasts. Biochem Biophys Res Commun (1978) 1.19
Isoprenylation of C-terminal cysteine in a G-protein gamma subunit. J Biol Chem (1990) 1.15
Saccharomyces cerevisiae STE14 gene is required for COOH-terminal methylation of a-factor mating pheromone. J Biol Chem (1990) 1.10
Characterization of isoprenoid involved in the post-translational modification of mammalian cell proteins. J Biol Chem (1989) 1.09
Degradation of a-factor by a Saccharomyces cerevisiae alpha-mating-type-specific endopeptidase: evidence for a role in recovery of cells from G1 arrest. Mol Cell Biol (1991) 1.02
Total synthesis of the lipopeptide a-mating factor of Saccharomyces cerevisiae. Biochem Biophys Res Commun (1989) 0.97
Total in vitro maturation of the Saccharomyces cerevisiae a-factor lipopeptide mating pheromone. Biochem Biophys Res Commun (1990) 0.91
Structure-activity relationships of the yeast alpha-factor. CRC Crit Rev Biochem (1986) 0.91
Regulation of alpha-factor production in Saccharomyces cerevisiae: a-factor pheromone-induced expression of the MF alpha 1 and STE13 genes. Mol Cell Biol (1989) 0.91
Solution phase synthesis of Saccharomyces cerevisiae a-mating factor and its analogs. Int J Pept Protein Res (1990) 0.89
Isolation and characterization of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by the mating hormone a-factor. Mol Gen Genet (1989) 0.86
Importance of the membrane in ligand-receptor interactions. Biochem Pharmacol (1990) 0.80
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg (2001) 11.58
Mapping striate and extrastriate visual areas in human cerebral cortex. Proc Natl Acad Sci U S A (1996) 4.69
Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology (1998) 3.79
Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol (1996) 3.50
Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg (1999) 3.32
Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science (1998) 3.04
Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs (2000) 2.82
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology (2000) 2.70
A 'pseudo-AIDS' syndrome following from fear of AIDS. Br J Psychiatry (1985) 2.69
Psychological support and counselling for patients with acquired immune deficiency syndrome (AIDS). Genitourin Med (1985) 2.59
HIV infection: increase in public awareness and anxiety. Br Med J (Clin Res Ed) (1987) 2.52
Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun (1998) 2.51
HTLV-III: should testing ever be routine? Br Med J (Clin Res Ed) (1986) 2.51
Epidural versus continuous transversus abdominis plane catheter technique for postoperative analgesia after abdominal surgery. Anaesth Intensive Care (2013) 2.51
Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology (2012) 2.50
The changing spectrum of fungal keratitis in south Florida. Ophthalmology (1994) 2.29
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol (1999) 2.28
Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother (1994) 2.23
Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med (1998) 2.15
Occupational strain and the incidence of coronary heart disease. Am J Epidemiol (1989) 2.10
Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation (1995) 2.07
Breeding difficulties. Vet Rec (2001) 2.07
The PTR family: a new group of peptide transporters. Mol Microbiol (1995) 2.02
Functional magnetic resonance imaging (FMRI) of the human brain. J Neurosci Methods (1994) 2.02
Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch Gen Psychiatry (1995) 2.00
Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory. Diabetes Technol Ther (1999) 1.95
Why AIDS is not a notifiable disease. S Afr Med J (1992) 1.92
Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis. Lancet (1987) 1.92
Dimethylthetin can substitute for glycine betaine as an osmoprotectant molecule for Escherichia coli. J Bacteriol (1987) 1.91
Ileal pouch-anal anastomosis. A single surgeon's experience with 100 consecutive cases. Ann Surg (1986) 1.91
The importance of radiating leg pain in assessing health outcomes among patients with low back pain. Results from the Veterans Health Study. Spine (Phila Pa 1976) (1998) 1.89
Polyoxin D inhibits growth of zoopathogenic fungi. Antimicrob Agents Chemother (1983) 1.89
Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry (2000) 1.83
Eight-year follow-up study of brain atrophy in patients with MS. Neurology (2002) 1.78
Chronic and recovered cases of sheep-associated malignant catarrhal fever in cattle. Vet Rec (1997) 1.78
Attenuated virulence of chitin-deficient mutants of Candida albicans. Proc Natl Acad Sci U S A (1995) 1.73
Endophthalmitis caused by gram-negative organisms. Arch Ophthalmol (1992) 1.72
Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med (1981) 1.71
Effects of ENU dosage on mouse strains. Mamm Genome (2000) 1.69
Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer (1977) 1.69
Utilization of methionine-containing peptides and their derivatives by a methionine-requiring auxotroph of Saccharomyces cerevisiae. J Biol Chem (1974) 1.68
Constitutional hepatic dysfunction (CHD; Gilbert's disease); a review with special reference to a characteristic increase and prolongation of the hyperbilirubinemic response to nicotinic acid. Medicine (Baltimore) (1972) 1.68
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol (2008) 1.68
Depression in grandparents raising grandchildren: results of a national longitudinal study. Arch Fam Med (1997) 1.67
Measles vaccination and neurological events. Lancet (1997) 1.66
Irreversible inhibition of biotin transport in yeast by biotinyl-p-nitrophenyl ester. Proc Natl Acad Sci U S A (1971) 1.66
The feasibility of a web-based surveillance system to collect health risk behavior data from college students. Health Educ Behav (2001) 1.66
Evaluation of a nurse specialist anticoagulant service. Clin Lab Haematol (1997) 1.66
Antitumor activity of sorafenib in FLT3-driven leukemic cells. Leukemia (2007) 1.65
Gastroduodenitis. A broader concept of peptic ulcer disease. Dig Dis Sci (1980) 1.59
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet (1994) 1.59
Corneal biopsy in the management of progressive microbial keratitis. Am J Ophthalmol (2000) 1.56
Expression and purification of the Saccharomyces cerevisiae alpha-factor receptor (Ste2p), a 7-transmembrane-segment G protein-coupled receptor. J Biol Chem (1997) 1.56
Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology (1999) 1.55
Evolution of homeobox genes: Q50 Paired-like genes founded the Paired class. Dev Genes Evol (1999) 1.55
Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline. Ophthalmology (1993) 1.54
Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b. Neurology (2003) 1.54
Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol (1993) 1.54
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol (2000) 1.54
Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int (2000) 1.52
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci U S A (1986) 1.51
Multiplicity of oligopeptide transport systems in Escherichia coli. J Bacteriol (1975) 1.51
Periocular atypical mycobacterial infections. Ophthalmology (1999) 1.50
Isolation and characterization of a Saccharomyces cerevisiae peptide transport gene. Mol Cell Biol (1994) 1.49
Regulation of the synthesis of adenylate cyclase in Escherichia coli by the cAMP -- cAMP receptor protein complex. Mol Gen Genet (1981) 1.49
Fungal lipopeptide mating pheromones: a model system for the study of protein prenylation. Microbiol Rev (1995) 1.48
Endogenous endophthalmitis caused by Histoplasma capsulatum var. capsulatum: a case report and literature review. Ophthalmology (2000) 1.46
Open adhesiolysis is more effective in reducing adhesion reformation than laparoscopic adhesiolysis in an experimental model. Br J Surg (2010) 1.45
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry (1997) 1.44
Integrated backscatter for quantification of left atrial spontaneous echo contrast. J Am Coll Cardiol (1996) 1.43
Sequential injection of 3% sodium tetradecyl sulfate and 20% sodium chloride in the treatment of refractory varicosity of the greater saphenous vein. J Dermatol Surg Oncol (1994) 1.43
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology (2005) 1.43
An Arabidopsis peptide transporter is a member of a new class of membrane transport proteins. Plant Cell (1994) 1.42
Effectiveness of glucose monitoring systems modified for the visually impaired. Diabetes Care (1993) 1.42
The Medication Reduction Project: combating polypharmacy in South Dakota elders through community-based interventions. S D J Med (1996) 1.41
Scleral buckle removal following retinal reattachment surgery: clinical and microbiologic aspects. Ophthalmic Surg (1993) 1.39
NEW DEVELOPMENTS IN THE TREATMENT OF COMPOUND FRACTURES. Ann Surg (1941) 1.39
Quantitation of colonic injury from argon laser, neodymium: YAG laser and monopolar electrocautery applied to flat mucosa and small sessile polyps of the canine colon. Gastrointest Endosc (1989) 1.39
Publishing and the Internet. Can J Anaesth (1995) 1.38
The comet tail artifact. J Ultrasound Med (1993) 1.36
Microbial keratitis in children. Ophthalmology (1998) 1.36
Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest (1992) 1.36
Peptide utilization in Pseudomonas aeruginosa: evidence for membrane-associated peptidase. J Bacteriol (1978) 1.36
Cloning of a second Arabidopsis peptide transport gene. Plant Physiol (1996) 1.36
Stereospecificity of tripeptide utilization in a methionine auxotroph of Escherichia coli K-12. J Bacteriol (1974) 1.35
NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol (2000) 1.34
A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes. EMBO J (1996) 1.34